Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Adjusting your budget mid month can be simple. Explore these quick tips to make the process easier.
21,890 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Bitcoin trades near the mid-$60,000s after testing $70,000 earlier this week. Analysts say long-term holder activity ...
Ripple’s XRP is trading in a tight range while key indicators hint at a potential breakout. Analysts diverge on direc...
A landmark U.S. refinery plan in Brownsville is unveiled but its first fuel production won’t come for years, leaving ...
As 2025 closes, KLX Energy Services faces a choppy energy market. This guide breaks down the Q4 2025 earnings landsca...
A look at five 2016 IPOs shows how a $1,000 investment in each would have fared through 2026, highlighting divergent ...
BlackRock has launched a new staked Ethereum ETF, ETHB, blending spot ETH exposure with on-chain staking. Early data ...
Skyworks and Qorvo announce a roughly $22 billion merger aiming to close in early 2027, signaling a major shift in RF...
When a CEO sells a sizable block of stock, investors take notice. This article breaks down the numbers behind imax so...
Ethereum’s chart flashed a buy signal after months of pressure, with prices hovering near the $2,320–$2,360 range as ...
A leading analyst warns of multi-year shortages coming optical as AI data-center growth strains suppliers. LUMENTUM a...
Amazon launches 1-hour and 3-hour delivery across dozens of U.S. markets, delivering faster options for groceries and...